Enbrel 50 MG/ML mini cartridgeml
Ended Awarded Last action
- Contract number
- SPE2DR26FS25L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,799
Award facts
- Contract value 100% obligated
- $18,799.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $18,799.15 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/mL mini cartridges, with a completion deadline of January 26, 2026. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), holds the primary $999,999,999.00 IDC with DLA Troop Support Medical extending through December 2026, which functions as a comprehensive global pharmaceutical support vehicle enabling delivery of a broad range of medications and medical supplies to military treatment facilities and healthcare programs worldwide.
Enbrel is a specialty biologic medication used in the treatment of rheumatoid arthritis, ankylosing spondylitis, and other inflammatory conditions, making this delivery order part of AmerisourceBergen's extensive portfolio supporting federal medical procurement across multiple therapeutic domains. The firm's demonstrated capability in fulfilling competitive federal contracts, combined with its dominant position as a pharmaceutical prime vendor to the Defense Health Agency and other government healthcare systems, positions it as a key strategic partner in the military's global medical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DR26FS25L?
SPE2DR26FS25L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26FS25L worth?
The government has obligated $18,799 on SPE2DR26FS25L.
Is contract SPE2DR26FS25L an order under another contract?
Yes. SPE2DR26FS25L is a delivery order under SPE2DR25D2204, an indefinite delivery contract.
Was contract SPE2DR26FS25L competed?
The extent of competition for SPE2DR26FS25L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award